BOSTON (CBS) – Local research finds a promising drug to treat certain lung cancers.

In Thursday’s New England Journal of Medicine, Dr. Eunice Kwak, at Mass General Hospital, reports daily doses of this targeted treatment were found to stop or reverse the growth of tumors, driven by changes in the in the anaplastic lymphoma kinase (ALK) gene found in some patients.

Dr. Kwak talks about the treatment with WBZ News Radio’s Diane Stern.

  Dr. Eunice Kwak from Mass General speaks with WBZ News Radio’s Diane Stern.

There’s a two to 7-percent incidence of these abnormalities in lung cancer patients, most of whom have a light or no-smoking history.

The clinical trial is on-going.

It’s supported by drugmaker Pfizer.

Comments (2)
  1. wayne rogers says:

    have 2 friends diagnosed with lung cancer

  2. CMHarney says:

    Would this be a trial for a patient who has just been diagnosed with lung metastasis from uterine cancer 3 years post hysterectomy w/o chemo or radiation

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s